Plunkett Research Online: SIGA Technologies Inc

SIGA TECHNOLOGIES INC (SIGA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus......



SIGA Technologies Inc
Ticker: SIGA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212 672-9100
Fax: 212 697-3130
Address: 31 East 62nd Street
New York, NY 10065 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Infectious Diseases
Vaccines
Antibiotics
Biothreat Rapid-Response Therapeutics
Mucosal Drug Delivery
Pharmaceuticals
Commercial-Stage
Contacts Description
Diem NguyenCEO/Director
Daniel LuckshireCFO/Chief Accounting Officer/Executive VP/Secretary
See More
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus......See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
TPOXX
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: